• Idris Boudhabhay, Chérif Titah, Alexis Talbot, Stéphanie Harel, Jérôme Verine, Guy Touchard, Sihem Kaaki, Eric Gabison, Vivien Vasseur, Martine Mauget-Faÿsse, and Thomas Sené.
• Department of Immuno-Hematology, Hôpital Saint-Louis.
• Medicine (Baltimore). 2018 Dec 1; 97 (52): e13638.

RationaleCrystal sorting histiocytosis (CSH) is a rare disorder that is morphologically characterized by the accumulation of monoclonal immunoglobulin crystals, predominantly of a kappa light chain type, within lysosomes of macrophages. CSH may result in a variety of clinical manifestations depending on the involved organs. In this case report, we aim to describe a patient with ophthalmic manifestations which lead to the diagnosis of multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy.Patient ConcernsA 60-year-old male patient presented with progressive bilateral decreased vision for 2 years.DiagnosisOphthalmic explorations showed bilateral macular and papillary edema, and multiple crystalline deposits in the anterior stromal cornea and in the retina. Laboratory tests showed nephrotic syndrome and renal dysfunction. Further work-up revealed IgG kappa multiple myeloma, with biopsy-proven combined crystalline podocytopathy and tubulopathy.InterventionsThe patient received chemotherapy (bortezomib, cyclophosphamide, and dexamethasone for 3 cycles, then bortezomib, lenalidomide, and dexamethasone).OutcomesDespite partial hematologic response and improvement of the papilledema and macular edema, the patient developed dialysis-dependent end-stage renal failure.LessonsThis report, highlighting the protean presentation of paraprotein-mediated injuries, provides additional information on the ocular anomalies not previously described that may be associated with crystal-storing histiocytosis.

19 keywords...

hide…